- This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
- Top stories: Germany launches week-long vaccination drive; US studies suggest vaccines hold strong against Delta variant; South Africa set to ease COVID-19 restrictions.
Have you read?
1. How COVID-19 is affecting the globe
Confirmed cases of COVID-19 have passed 224.6 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.63 million. More than 5.7 billion vaccination doses have been administered globally, according to Our World in Data.
The Australian state of New South Wales reported 1,257 new confirmed locally acquired COVID-19 cases today, down from 1,262 the day before.
New Zealand has extended a strict lockdown in Auckland for at least another week in an effort to prevent small clusters of COVID-19 from spreading further.
It comes as New Zealand announced it has purchased 500,000 doses of the Pfizer/BioNTech COVID-19 vaccine from Denmark.
Australia has also purchased an additional 1 million doses of the Moderna COVID-19 vaccine from the European Union.
South Africa is set to ease its COVID-19 restrictions and shorten a nationwide curfew after a decline in infections.
South Africa's health regulator has also approved Pfizer/BioNTech's COVID-19 vaccine for use in children aged 12 and over.
Novavax announced on Friday it expects at least 2 billion doses of its COVID-19 vaccine to be available next year.
Germany's vaccine oversight body has recommended that women who are pregnant or breastfeeding should be vaccinated against COVID-19 with an mRNA-based shot.
Some of the world's poorest countries have asked for more support to meet vaccination and quarantine requirements and costs so they can take part in the COP26 climate summit in Scotland.
2. Germany launches week-long vaccine push
German Chancellor Angela Merkel has called on residents to take advantage of a week-long COVID-19 vaccination campaign. Free jabs will be available at places such as shops, football grounds and mosques.
"Never was it simpler to get a vaccination. Never has it been quicker," Merkel said in her weekly podcast, adding people could from Monday get a dose without an appointment on public transport and at places of worship and sports facilities.
There are concerns that the country's vaccination rate of around 62% will not be enough to prevent a wave of infections over the winter.
"To get through autumn and winter, we must convince more people to get vaccinated," Merkel said. "I ask you: protect yourself and other people. Get vaccinated."
India’s leading COVID-19 last-mile responders
Each of our Top 50 social enterprise last mile responders and multi-stakeholder initiatives is working across four priority areas of need: Prevention and protection; COVID-19 treatment and relief; inclusive vaccine access; and securing livelihoods. The list was curated jointly with regional hosts Catalyst 2030’s NASE and Aavishkaar Group. Their profiles can be found on www.wef.ch/lastmiletop50india.
Top Last Mile Partnership Initiatives to collaborate with:
#BackTheFrontline - Dasra
Covid Action Collab
Covid Livelihoods Coalition – CoLive
Migrants Resilience Collaborative
Rapid Rural Community Response (RCRC)
Rural Access Coalition
Saath Nirbhar - vartaLeap Coalition and ComMutiny
Sanjha Collective - Goonj
Top 50 Last Mile Responders to get behind:
Barefoot College International
Center for Wildlife Studies
Society Of Development Alternatives
Doctors For You
Dream a Dream
Eleutheros Christian Society
Every Infant Matters
Healing Fields Foundation
Indian Society of Agribusiness Professionals
MAHAN Trust, Melghat
Mann Deshi Foundation
Mission Oxygen - Democracy
SEWA Cooperative Federation
Spandan Samaj Seva Samiti
Study Hall Educational Foundation (SHEF)
Sustainable Environment and Ecological Development Society (SEEDS)
Transforming Rural India Foundation
Ziqitza Health Care Limited
3. COVID-19 vaccines hold strong against Delta
Three US studies suggest that COVID-19 vaccines continue to offer strong protection against hospitalization and death, even against the highly transmissible Delta variant.
However, the studies did suggest that protection appears to be waning among older populations - especially people aged 75 and above.
Data on hospitalization from nine US states during the period when Delta was the dominant variant showed that Moderna's COVID-19 vaccine was 95% effective at preventing hospitalization, compared with 80% for Pfizer and 60% for Johnson & Johnson.